Perspectives on the use of data mining in pharmaco-vigilance (Q33225414)

24 July 2017

1 reference

title

Perspectives on the use of data mining in pharmaco-vigilance (English)

1 reference

24 July 2017

0 references

5

Manfred Hauben

1 reference

24 July 2017

June Almenoff

1

1 reference

24 July 2017

Joseph M Tonning

2

1 reference

24 July 2017

A Lawrence Gould

3

1 reference

24 July 2017

Ana Szarfman

4

1 reference

24 July 2017

Rita Ouellet-Hellstrom

6

1 reference

24 July 2017

Robert Ball

7

1 reference

24 July 2017

Ken Hornbuckle

8

1 reference

24 July 2017

Louisa Walsh

9

1 reference

24 July 2017

Chuen Yee

10

1 reference

24 July 2017

Susan T Sacks

11

1 reference

24 July 2017

Nancy Yuen

12

1 reference

24 July 2017

Vaishali Patadia

13

1 reference

24 July 2017

Michael Blum

14

1 reference

24 July 2017

Mike Johnston

15

1 reference

24 July 2017

Charles Gerrits

16

1 reference

24 July 2017

Harry Seifert

17

1 reference

24 July 2017

Karol Lacroix

18

1 reference

24 July 2017

1 January 2005

1 reference

24 July 2017

1 reference

24 July 2017

28

1 reference

24 July 2017

11

1 reference

24 July 2017

981-1007

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-200528110-00002

24 July 2017

0 references

cites work

Re: "Confounding by indication and channeling over time: the risks of beta2-agonists".

1 reference

12 December 2020

Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis

1 reference

12 December 2020

On the assessment of adverse drug reactions from spontaneous reporting systems: the influence of under-reporting on odds ratios

1 reference

12 December 2020

Quantitative methods in pharmacovigilance: focus on signal detection

1 reference

12 December 2020

1 reference

12 December 2020

A tree-based scan statistic for database disease surveillance

1 reference

12 December 2020

A Bayesian neural network method for adverse drug reaction signal generation.

1 reference

12 December 2020

Use of measures of disproportionality in pharmacovigilance: three Dutch examples

1 reference

12 December 2020

Data mining in the US Vaccine Adverse Event Reporting System (VAERS): early detection of intussusception and other events after rotavirus vaccination

1 reference

12 December 2020

Variability in patterns of drug usage

1 reference

12 December 2020

Pharmacovigilance: a science or fielding emergencies?

1 reference

12 December 2020

Increased reporting of adverse reactions to ACE inhibitors associated with limitations to drug reimbursement for angiotensin-II receptor antagonists.

1 reference

12 December 2020

Pharmacovigilance in the 21st century: new systematic tools for an old problem

1 reference

12 December 2020

Postmarketing safety surveillance for typhoid fever vaccines from the Vaccine Adverse Event Reporting System, July 1990 through June 2002.

1 reference

12 December 2020

Testing and implementing signal impact analysis in a regulatory setting: results of a pilot study.

1 reference

12 December 2020

Use of risk-adjusted CUSUM and RSPRT charts for monitoring in medical contexts

1 reference

12 December 2020

Application of an empiric Bayesian data mining algorithm to reports of pancreatitis associated with atypical antipsychotics

1 reference

12 December 2020

Detecting drug–drug interactions using a database for spontaneous adverse drug reactions: an example with diuretics and non-steroidal anti-inflammatory drugs

1 reference

12 December 2020

Risk-adjusted sequential probability ratio tests: applications to Bristol, Shipman and adult cardiac surgery.

1 reference

12 December 2020

Trimethoprim-induced hyperkalaemia -- lessons in data mining

1 reference

12 December 2020

Statistical techniques for signal generation: the Australian experience

1 reference

12 December 2020

Postmarketing surveillance of lovastatin and simvastatin exposure during pregnancy

1 reference

12 December 2020

Practical pharmacovigilance analysis strategies

1 reference

12 December 2020

The effect of backgrounds in safety analysis: the impact of comparison cases on what you see

1 reference

12 December 2020

Confounding by indication and channeling over time: the risks of beta 2-agonists

1 reference

12 December 2020

A retrospective evaluation of a data mining approach to aid finding new adverse drug reaction signals in the WHO international database

1 reference

12 December 2020

Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports

1 reference

12 December 2020

Pharmacoepidemiology and gastroenterology: a close couple

1 reference

12 December 2020

False-positives in spontaneous reporting: should we worry about them?

1 reference

12 December 2020

Disproportionality analysis using empirical Bayes data mining: a tool for the evaluation of drug interactions in the post‐marketing setting

1 reference

12 December 2020

Photophobia following smallpox vaccination

1 reference

12 December 2020

Impact analysis of signals detected from spontaneous adverse drug reaction reporting data

1 reference

12 December 2020

From association to alert--a revised approach to international signal analysis

1 reference

12 December 2020

Application of data mining techniques in pharmacovigilance

1 reference

12 December 2020

Effects of coding dictionary on signal generation: a consideration of use of MedDRA compared with WHO-ART

1 reference

12 December 2020

A brief primer on automated signal detection

1 reference

12 December 2020

Factors influencing the spontaneous reporting of adverse drug reactions--the experience of the Slovak Republic.

1 reference

12 December 2020

Understanding vaccine safety information from the Vaccine Adverse Event Reporting System

1 reference

12 December 2020

Introducing triage logic as a new strategy for the detection of signals in the WHO Drug Monitoring Database

1 reference

12 December 2020

Harmonisation in pharmacovigilance

1 reference

12 December 2020

Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database

1 reference

12 December 2020

A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001

1 reference

12 December 2020

A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions.

1 reference

12 December 2020

The reporting odds ratio and its advantages over the proportional reporting ratio

1 reference

12 December 2020

Early postmarketing drug safety surveillance: data mining points to consider

1 reference

12 December 2020

Non-sedating antihistamine drugs and cardiac arrhythmias -- biased risk estimates from spontaneous reporting systems?

1 reference

12 December 2020

Clinical judgment, common sense and adverse reaction reporting

1 reference

12 December 2020

Reply: The evaluation of data mining methods for the simultaneous and systematic detection of safety signals in large databases: lessons to be learned

1 reference

12 December 2020

Prescribing patterns in patients using new antidepressants

1 reference

12 December 2020

Temporal trends in spontaneous reporting of unlabelled adverse drug reactions

1 reference

12 December 2020

The reporting odds ratio versus the proportional reporting ratio:‘deuce’

1 reference

12 December 2020

Drug-induced pancreatitis: lessons in data mining

1 reference

12 December 2020

10.2165/00002018-200528110-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

24 July 2017

0 references

1 reference